| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
James R McNab last filed a Form 4 in May 2017, as Director at CRIS. James R McNab's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 50,000 shares of CRIS. The CRIS filings lean toward selling, a net 450,000 shares.
James R McNab has 7 Form 4 filings on record from January 2015 to May 2017, all as Director at Curis (CRIS), 2015–2017.
The 16 reported transactions were 13 open-market sales and 3 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $1.1M.
The largest open-market sale was 146,694 shares of CRIS at an average $2.61 on April 27, 2017, about $383K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2017. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 5, 2017 | CRIS Curis Inc | Director | Sell | 76,276 | $2.04 | $155,424.00 | -60.4% | |
| May 2, 2017 | CRIS Curis Inc | Director | Sell | 116,708 | $2.38 | $278,037.28 | -48.0% | |
| Apr 27, 2017 | CRIS Curis Inc | Director | Sell | 146,694 | $2.61 | $383,019.32 | -37.6% | |
| Apr 24, 2017 | CRIS Curis Inc | Director | Sell | 110,322 | $2.59 | $285,682.37 | -8.0% |